BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

NanoViricides, Inc. 

135 Wood Street, Suite 205

West Haven  Connecticut  06516  U.S.A.
Phone: n/a Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
NanoViricides, Inc. (NNVC.PK) Says Injectable FluCide™ Selected In Top Ten Project To Watch - Presentation Today At The Therapeutics Area Partnerships Meeting In Boston 11/20/2014 1:53:54 PM
NanoViricides, Inc. (NNVC.PK) CEO, Eugene Seymour, MD, MPH, Invited To Discuss The Current Ebola Outbreak On Fox Business News At 9PM EDT Tonight 11/18/2014 4:33:00 PM
NanoViricides, Inc. (NNVC.PK) Files Quarterly Report - Reports Further Improved Strong Cash Position Sufficient For Clinical Trials Of Its First Two Drug Candidates 11/17/2014 4:27:07 PM
NanoViricides, Inc. (NNVC.PK) Signs CRADA For Material Transfer With USAMRIID For Evaluating Its Anti-Ebola Drug Candidates 10/27/2014 10:57:38 AM
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/20/2014 3:28:01 AM
NanoViricides, Inc. (NNVC.PK) CEO, Eugene Seymour, MD, MPH, Invited To Discuss The Current Ebola Outbreak On Fox Business News At 9PM EDT Tonight 10/7/2014 1:24:09 PM
NanoViricides, Inc. (NNVC.PK) Files Annual Report 10/1/2014 11:09:56 AM
NanoViricides, Inc. (NNVC.PK) Reports Flucide™ Samples Were Shipped To Basi For Start Of Safety/Toxicology Studies; Also Reports That Ebola Drug Candidates Are Being Synthesized 10/1/2014 10:52:28 AM
NanoViricides, Inc. (NNVC.PK) Reports That It Has Designed And Commenced Synthesis Of Novel Ebola Drug Candidates; Dr. Seymour To Present At Rodman & Renshaw Conference In New York Today 9/9/2014 12:12:03 PM
NanoViricides, Inc. (NNVC.PK) Raises Approximately $7.5 Million Upon Exercise Of Certain Old Warrants By Its Long Standing Investors 9/8/2014 6:34:57 AM
12345678910...